Company Filing History:
Years Active: 2016-2020
Title: Delphine Rolland: Innovator in Cancer Research
Introduction
Delphine Rolland is a prominent inventor based in Ann Arbor, MI (US). She has made significant contributions to the field of cancer research, particularly in the area of gene fusions and their implications for diagnosis and therapy.
Latest Patents
Delphine Rolland holds 2 patents. Her latest patents include "Recurrent gene fusions in cutaneous CD30-positive lymphoproliferative disorders," which provides kits, compositions, and methods for cancer diagnosis, research, and therapy. This invention focuses on recurrent gene fusions, such as those involving TYK2, as diagnostic markers and clinical targets for conditions like lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma. Another significant patent is related to "Compositions and methods relating to fusion protein biomarkers." This invention offers fusion proteins as biomarkers specific for chromosomal translocation-based conditions, including cancer, and outlines methods for detecting and quantifying these biomarkers.
Career Highlights
Delphine Rolland is affiliated with the University of Michigan, where she continues her research and innovation in cancer diagnostics and therapeutics. Her work has garnered attention for its potential impact on clinical practices and patient outcomes.
Collaborations
Delphine collaborates with notable colleagues, including Kojo Elenitoba-Johnson and Megan Lim, enhancing the research environment and fostering innovation in their shared field.
Conclusion
Delphine Rolland's contributions to cancer research through her patents and collaborations highlight her role as a key innovator in the field. Her work continues to pave the way for advancements in cancer diagnosis and treatment.